In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin
- 1 December 2000
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (2) , 85-93
- https://doi.org/10.1016/s0928-0987(00)00149-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) miceBritish Journal of Pharmacology, 1999
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- The Place of Quinolones in Everyday Clinical PracticeChemotherapy, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Quantitative microdialysis under transient conditionsAnalytical Chemistry, 1993
- Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitroLife Sciences, 1990
- Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.Journal of Histochemistry & Cytochemistry, 1989
- Pharmacokinetic Disposition of Quinolones in Human Body Fluids and TissuesClinical Pharmacokinetics, 1989
- Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityJournal of Medicinal Chemistry, 1980